title: Variation in TP63 is associated with lung adenocarcinoma in the UK population.
abstract: BACKGROUND
  Variation at TP63 has recently been shown to be associated with lung adenocarcinoma in the Asian population.
  
  
  METHODS
  To investigate how this finding translates to the European population we compared the genotypes of SNPs annotating the TP63 locus at 3q28 in 4,462 lung cancer patients, including 911 with adenocarcinoma, and 8,235 controls from the United Kingdom.
  
  
  RESULTS
  A statistically significant association between adenocarcinoma risk and SNP genotype was shown: rs10937405, OR = 1.21, P = 1.82 × 10(-4); rs17429138, OR = 1.23, P = 7.49 × 10(-5); and rs4396880, OR = 1.21, P = 2.03 × 10(-4). Haplotype analysis was consistent with a single TP63 risk locus defined by SNPs rs10937405, rs17429138, and rs4396880. While no association between SNPs and small cell lung cancer was shown, the rs10937405 and rs439680 associations were significant for squamous cancer (respective P-values, 0.0022 and 0.02).
  
  
  CONCLUSIONS
  These findings show TP63 variation is a risk factor for the development of lung adenocarcinoma in the UK population. Furthermore, they provide additional insight into the subtype-specificity of the 3q28 lung cancer association.
  
  
  CONCLUSIONS
  Our data confirm the association of 3q28 with lung adenocarcinoma and that this association is not confined to the Asian population. Elucidating the functional basis of this association will be contingent on future fine mapping of the TP63 loci.
authors: Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey, UK.
authors: Yufei
authors: Y
authors: Wang
authors: Peter
authors: P
authors: Broderick
authors: Athena
authors: A
authors: Matakidou
authors: Jayaram
authors: J
authors: Vijayakrishnan
authors: Timothy
authors: T
authors: Eisen
authors: Richard S
authors: RS
authors: Houlston
references: Carcinogenesis. 2008 Feb;29(2):273-81
references: 18048390
references: Nature. 2008 Apr 3;452(7187):633-7
references: 18385738
references: Science. 2005 Oct 14;310(5746):321-4
references: 16224025
references: Science. 2002 Jun 21;296(5576):2225-9
references: 12029063
references: Gen Thorac Cardiovasc Surg. 2008 Feb;56(2):43-53
references: 18297458
references: Nat Genet. 2008 Dec;40(12):1404-6
references: 18978790
references: Nat Genet. 2008 May;40(5):616-22
references: 18385676
references: CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108
references: 15761078
references: Bioinformatics. 2005 Jan 15;21(2):263-5
references: 15297300
references: Nature. 2007 Jun 7;447(7145):661-78
references: 17554300
references: Cancer Res. 2009 Aug 15;69(16):6633-41
references: 19654303
references: Nat Genet. 2008 Dec;40(12):1407-9
references: 18978787
references: Cell Cycle. 2007 Feb 1;6(3):300-4
references: 17264676
references: BMC Cancer. 2008 Aug 20;8:244
references: 18715499
references: Am J Hum Genet. 2009 Nov;85(5):679-91
references: 19836008
references: Mol Cancer Res. 2004 Jul;2(7):371-86
references: 15280445
references: Nat Genet. 2010 Oct;42(10):893-6
references: 20871597
references: Int J Epidemiol. 2006 Feb;35(1):34-41
references: 16155052
references: Br J Cancer. 2007 Nov 5;97(9):1305-9
references: 17895893
references: Oncogene. 2000 Jun 22;19(27):3126-30
references: 10871867
references: Am J Hum Genet. 2007 Sep;81(3):559-75
references: 17701901
references: Nature. 2008 Apr 3;452(7187):638-642
references: 18385739